Press Releases
Swing Therapeutics Closes $10.3M Series A Funding Round
Swing Therapeutics, a digital therapeutics company developing evidence-backed treatments for autoimmune and chronic pain conditions, today announced that it has closed a $10.3M Series A funding round led by JAZZ Venture Partners.
Read the Article
Recent Comments